| Direct and indirect cost burden and change of employment status in treatment-resistant depression: a matched-cohort study using a US commercial claims database TB Amos, N Tandon, P Lefebvre, D Pilon, RL Kamstra, I Pivneva, ... The Journal of clinical psychiatry 79 (2), 5360, 2018 | 142 | 2018 |
| Treatment patterns, health care resource utilization, and spending in Medicaid beneficiaries initiating second-generation long-acting injectable agents versus oral atypical … D Pilon, N Tandon, MH Lafeuille, R Kamstra, B Emond, P Lefebvre, ... Clinical Therapeutics 39 (10), 1972-1985. e2, 2017 | 92 | 2017 |
| Adherence, healthcare resource utilization and Medicaid spending associated with once-monthly paliperidone palmitate versus oral atypical antipsychotic treatment among adults … D Pilon, E Muser, P Lefebvre, R Kamstra, B Emond, K Joshi BMC psychiatry 17, 1-18, 2017 | 48 | 2017 |
| Treatment patterns in Medicaid patients with schizophrenia initiated on a first-or second-generation long-acting injectable versus oral antipsychotic D Pilon, K Joshi, N Tandon, MH Lafeuille, RL Kamstra, B Emond, ... Patient preference and adherence, 619-629, 2017 | 47 | 2017 |
| Real-world adherence and economic outcomes associated with paliperidone palmitate versus oral atypical antipsychotics in schizophrenia patients with substance-related disorders … K Joshi, MH Lafeuille, R Kamstra, S Tiggelaar, P Lefebvre, E Kim, Y Yue, ... Journal of Comparative Effectiveness Research 7 (2), 121-133, 2018 | 24 | 2018 |
| HbA1c control and cost-effectiveness in patients with type 2 diabetes mellitus initiated on canagliflozin or a glucagon-like peptide 1 receptor agonist in a real-world setting CH Wysham, D Pilon, M Ingham, MH Lafeuille, B Emond, R Kamstra, ... Endocrine Practice 24 (3), 273-288, 2018 | 18 | 2018 |
| Hospitalizations in immigrants and nonimmigrants diagnosed with chronic hepatitis C infection in Quebec R Kamstra, L Azoulay, R Steele, MB Klein, C Greenaway Clinical Infectious Diseases 63 (11), 1439-1448, 2016 | 11 | 2016 |
| Economic impact in Medicaid beneficiaries with schizophrenia and cardiometabolic comorbidities treated with once-monthly paliperidone palmitate vs. oral atypical antipsychotics MH Lafeuille, N Tandon, S Tiggelaar, R Kamstra, P Lefebvre, E Kim, ... Drugs-Real World Outcomes 5, 81-90, 2018 | 10 | 2018 |
| An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic … CH Wysham, P Lefebvre, D Pilon, MH Lafeuille, B Emond, R Kamstra, ... Journal of Diabetes and its Complications 33 (2), 140-147, 2019 | 9 | 2019 |
| Treatment patterns and Medicaid spending in comorbid schizophrenia populations: once-monthly paliperidone palmitate versus oral atypical antipsychotics R Kamstra, D Pilon, P Lefebvre, B Emond, K Joshi Current medical research and opinion 34 (8), 1377-1388, 2018 | 8 | 2018 |
| Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual … CH Wysham, D Pilon, M Ingham, MH Lafeuille, B Emond, R Kamstra, ... Current medical research and opinion 34 (6), 1125-1133, 2018 | 8 | 2018 |
| Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials R Kamstra, M Durkin, J Cai, B Bookhart, MH Lafeuille, D Pilon, ... Journal of Medical Economics 22 (3), 280-287, 2019 | 7 | 2019 |
| Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis D Pilon, TB Amos, R Kamstra, AM Manceur, AC El Khoury, P Lefebvre Current Medical Research and Opinion 35 (1), 41-49, 2019 | 7 | 2019 |
| N‐(2, 4)‐dinitrophenyl‐L‐arginine interacts with EphB4 and functions as an EphB4 Kinase modulator RL Kamstra, A Freywald, WB Floriano Chemical biology & drug design 86 (4), 476-486, 2015 | 7 | 2015 |
| Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a … S Brunton, HM Rozjabek, D Pilon, MH Lafeuille, R Kamstra, W Wynant, ... Current Medical Research and Opinion, 2019 | 6* | 2019 |
| Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors CH Wysham, P Lefebvre, D Pilon, M Ingham, MH Lafeuille, B Emond, ... BMC endocrine disorders 17, 1-13, 2017 | 5 | 2017 |
| Predictors of overall survival (OS) in veterans with non-metastatic castration resistant prostate cancer (nmCRPC). AD Fuld, Y Young-Xu, S Li, D Pilon, R Bhak, E Duchesneau, M Hellstern, ... Journal of Clinical Oncology 36 (15_suppl), e17057-e17057, 2018 | 4 | 2018 |
| Identifying potential selective fluorescent probes for cancer-associated protein carbonic anhydrase IX using a computational approach RL Kamstra, WB Floriano Journal of Molecular Graphics and Modelling 54, 184-193, 2014 | 4 | 2014 |
| Treatment patterns in Medicaid patients with schizophrenia initiated on a first-or second-generation long-acting injectable versus oral antipsychotic. Patient Prefer Adherence … D Pilon, K Joshi, N Tandon, M Lafeuille, RL Kamstra, B Emond | 4 | |
| Creating and virtually screening databases of fluorescently-labelled compounds for the discovery of target-specific molecular probes RL Kamstra, S Dadgar, J Wigg, MA Chowdhury, CP Phenix, WB Floriano Journal of computer-aided molecular design 28, 1129-1142, 2014 | 3 | 2014 |
